Sort   by:  
 Page size 
UnknownTargeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies.
Not available
S-EPMC8267708 | biostudies-literature
UnknownNivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
Not available
S-EPMC5569692 | biostudies-literature
UnknownNivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
Not available
S-EPMC5569693 | biostudies-literature
UnknownTreatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design.
Not available
S-EPMC5469580 | biostudies-literature
UnknownPersonalized medicine and treatment approaches in non-small-cell lung carcinoma.
Not available
S-EPMC3513233 | biostudies-literature
UnknownGlobal research landscape and trends of lung cancer immunotherapy: A bibliometric analysis.
Not available
S-EPMC9751816 | biostudies-literature
UnknownCirculating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
Not available
S-EPMC6582501 | biostudies-literature
UnknownMultiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities.
Not available
S-EPMC12949428 | biostudies-literature
UnknownTargeting KRAS-Mutant Non-Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations.
Not available
S-EPMC7723684 | biostudies-literature
UnknownNivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
Not available
S-EPMC6075826 | biostudies-literature
Sort   by:  
 Page size